CymitQuimica logo

CAS 2289728-58-9

:

Trier par

Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 produits concernés.
  • N-[4-(7-Methoxyquinolin-4-yl)benzyl]sulfamide

    CAS :
    Formule :C17H17N3O3S
    Degré de pureté :98%
    Couleur et forme :Solid
    Masse moléculaire :343.4002

    Ref: IN-DA01LIIO

    1mg
    131,00€
    5mg
    139,00€
    10mg
    167,00€
    25mg
    213,00€
    50mg
    253,00€
    100mg
    586,00€
    250mg
    À demander
  • N-[4-(7-Methoxyquinolin-4-Yl)Benzyl]Sulfamide

    CAS :
    N-[4-(7-Methoxyquinolin-4-Yl)Benzyl]Sulfamide
    Degré de pureté :99%
    Masse moléculaire :343.4g/mol

    Ref: 54-OR1022883

    25mg
    À demander
    50mg
    À demander
    100mg
    466,00€
    250mg
    775,00€
  • Enpp-1-IN-1

    CAS :
    Enpp-1-IN-1
    Degré de pureté :≥95%
    Masse moléculaire :343.4g/mol

    Ref: 54-BUP04347

    1mg
    194,00€
    5mg
    392,00€
    10mg
    604,00€
    25mg
    983,00€
    50mg
    1.278,00€
    100mg
    1.723,00€
  • Enpp-1-IN-1

    CAS :
    Enpp-1-IN-1 is an inhibitor of Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1)
    Formule :C17H17N3O3S
    Degré de pureté :97.52%
    Couleur et forme :Solid
    Masse moléculaire :343.4
  • N-[4-(7-Methoxyquinolin-4-yl)benzyl]sulfamide

    CAS :
    Degré de pureté :98.0%
    Masse moléculaire :343.099062404

    Ref: 10-F547161

    1mg
    À demander
    25mg
    À demander
    50mg
    À demander
    100mg
    À demander
    250mg
    À demander
  • MV 658

    CAS :
    <p>MV 658 is a visually catalytic and selective copper-based agent with a novel mechanism of action. It is designed for the treatment of tuberculosis, HIV infection, and other encapsulated pathogens. The catalytic activity of MV 658 is based on the ability to selectively oxidize uracil to uric acid, which can then be converted to sulfur by UV light. This process has been shown to inhibit DNA synthesis in organisms, as well as research into its potential use in the treatment of pulmonary tuberculosis. MV 658 is a promising strategy for treatment of tuberculosis and HIV infections, with no cross-resistance observed in vitro against common strains of bacteria.</p>
    Formule :C17H17N3O3S
    Degré de pureté :Min. 95%
    Masse moléculaire :343.4 g/mol

    Ref: 3D-FM172557

    ne
    À demander